Taurine supplementation recovered hepatic GR activity in diabetic rats [114], whereas hepatic GPx levels remained unaltered by taurine supplementation in type I and type II diabetic mice [105]
CRD42022382594 Graphical Abstract Similar content being viewed by others Introduction Semaglutide, administered s.c., has shown superior efficacy compared with other glucose-lowering agents, including its oral formulation, in reducing HbA 1c and in facilitating weight loss in individuals with type 2 diabetes [1, 2]
meclinic.net and the MCS logo are trademarks or registered trademarks of ME CLINIC SEOUL headquarters located at 376 Gangnamdaero, Gangnamgu, Seoul, Republic of Korea | [email protected] | +82-10-3118-7591 : 825-8 9 | : 1661-5580 | : | : 214-14-92106 M-2022-01-08-6743 | :
Adding cagrilintide to tirzepatide Theoretical protocol (not clinically studied): If on tirzepatide 10-15mg: Stable on tirzepatide for 4+ weeks Continue tirzepatide at current dose Add cagrilintide 0.6mg weekly Standard cagrilintide titration to 2.4mg Rationale: Tirzepatide is dual GIP/GLP-1 (very powerful alone) Adding amylin pathway could theoretically enhance No clinical data on this combination Uncertain if additional benefit over tirzepatide alone Concerns: GI side effects may be severe (both slow gastric emptying) Tirzepatide already produces 15-22% weight loss alone Unclear if cagrilintide adds meaningful benefit Expensive combination Verdict: Wait for clinical data
This can lead to pernicious anemia